Saudi Arabia Osteoporosis Drugs Market By Type (Primary Osteoporosis & Secondary Osteoporosis), Drugs (Bisphosphonates, Monoclonal Antibodies, Hormone Therapy & Others), Drugs Type (Branded & Generic), Route of Administration (Injectable, Oral & Others), Gender (Female & Male), Age Group (Geriatrics, Adults & Pediatrics), End User (Hospitals, Specialty Clinics, Homecare & Others), Distribution Channel (Direct Tender, Retail Sales & Others) Industry Trends and Forecasts to 2029.
Data Bridge Market Research analyses that the Saudi Arabia osteoporosis drugs market will grow at a CAGR of 2.9% during the forecast period of 2022 to 2029. According to the International Osteoporosis Foundation (IOF), ‘osteoporosis, which means porous bone, is a disease in which the quality and density of bone are reduced. As bones become more fragile and porous, the risk of fracture is greatly increased. The loss of bone occurs progressively and silently. Often there are no symptoms until the first fracture occurs.
Saudi Arabia Osteoporosis Drugs Market Analysis and Insights
The different types of medications for osteoporosis are available in the market. The bisphosphonates are usually the first choice for treatment of osteoporosis. These includes Risedronate (Actonel), a weekly or monthly pill, Alendronate (Fosamax), a weekly pill, Zoledronic acid (Reclast), an annual IV infusion and Ibandronate (Boniva), a monthly pill or quarterly intravenous (IV) infusion.
With age, some of the bone cells begin to dissolve bone matrix, the process is called resorption, while new bone cells deposit osteoid, and the process is called formation. This process is called as remodeling. For people with osteoporosis, bone loss outpaces the growth of new bone. Bones become brittle, porous and prone to fracture. Though osteoporosis fractures can occur in other bones also, but he most commonly osteoporosis fractures occurs at wrist, spine or the hip.
Request Access for Saudi Arabia Osteoporosis Drugs Market
Buy Now Access Full Report:- https://www.databridgemarketresearch.com/reports/saudi-arabia-osteoporosis-drug-market
Competitive Landscape and Saudi Arabia Osteoporosis Drugs Market Share Analysis
Browse The Table of Contents And List of Figures: https://www.databridgemarketresearch.com/toc/?dbmr=saudi-arabia-osteoporosis-drug-market
Major TOC of the Saudi Arabia Osteoporosis Drugs Market Report
Saudi Arabia Osteoporosis Drugs Market Scope
The osteoporosis drugs market is categorized into eight notable segments based on type, drugs, drugs type, route of administration, gender, age group, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
· Primary Osteoporosis
· Secondary Osteoporosis.
On the basis of type, Saudi Arabia osteoporosis drugs market is segmented into primary osteoporosis and secondary osteoporosis.
· Monoclonal Antibodies
· Hormone Therapy
On the basis of drugs, Saudi Arabia osteoporosis drugs market is segmented into bisphosphonates, monoclonal antibodies, hormone therapy and others.
On the basis of drugs type, Saudi Arabia osteoporosis drugs market is segmented into branded and generic.
Route of Administration
On the basis of route of administration, Saudi Arabia osteoporosis drugs market is segmented into injectable, oral and others.
On the basis of gender, Saudi Arabia osteoporosis drugs market is segmented into female and male.
On the basis of age group, Saudi Arabia osteoporosis drugs market is segmented into geriatrics, adults and pediatrics.
· Specialty Clinics
On the basis of end user, Saudi Arabia osteoporosis drugs market is segmented into hospitals, specialty clinics, homecare and others.
· Direct Tender
· Retail Sales
On the basis of distribution channel, Saudi Arabia osteoporosis drugs market is segmented into direct tender, retail sales and others.
Competitive Landscape and Osteoporosis Drugs Market Share Analysis
Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Saudi Arabia presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to osteoporosis durgs market.
Some of the major players operating in the Saudi Arabia osteoporosis drugs market are
· Eli Lilly and Company,
· Novartis AG,
· Amgen Inc.,
· Tabuk pharmaceuticals,
· Hikma Pharmaceuticals PLC,
· Pfizer Inc.,
· Merck KGaA, Apotex Inc.,
· ABIOGEN PHARMA S.p.A.,
· Sudair Pharma,
· Fresenius SE & Co. KGaA,
· Hayat Pharmaceutical Industries Co. PLC,
· and SAJA Pharmaceuticals among others.
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Data Bridge Market Research
Email: [email protected]
Browse Related Reports@